Sinew Pharma Inc. 6634.TWO Stock
Sinew Pharma Inc. Price Chart
Sinew Pharma Inc. 6634.TWO Financial and Trading Overview
| Sinew Pharma Inc. stock price | 63.1 TWD |
| Previous Close | 80.3 TWD |
| Open | 80.5 TWD |
| Bid | 80.1 TWD x 0 |
| Ask | 80.7 TWD x 0 |
| Day's Range | 80.1 - 81 TWD |
| 52 Week Range | 77.7 - 138 TWD |
| Volume | 35.54K TWD |
| Avg. Volume | 70.74K TWD |
| Market Cap | 5.63B TWD |
| Beta (5Y Monthly) | 1.184246 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.07 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6634.TWO Valuation Measures
| Enterprise Value | 4.22B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 17166.465 |
| Price/Book (mrq) | 3.860505 |
| Enterprise Value/Revenue | 12863.017 |
| Enterprise Value/EBITDA | -32.886 |
Trading Information
Sinew Pharma Inc. Stock Price History
| Beta (5Y Monthly) | 1.184246 |
| 52-Week Change | 0.37% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 138 TWD |
| 52 Week Low | 77.7 TWD |
| 50-Day Moving Average | 84.62 TWD |
| 200-Day Moving Average | 99.96 TWD |
6634.TWO Share Statistics
| Avg. Volume (3 month) | 70.74K TWD |
| Avg. Daily Volume (10-Days) | 47.48K TWD |
| Shares Outstanding | 69.77M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -45252.43% |
| Gross Margin | 88.41% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -6.039% |
| Return on Equity (ttm) | -9.26% |
Income Statement
| Revenue (ttm) | 328K TWD |
| Revenue Per Share (ttm) | 0.005 TWD |
| Quarterly Revenue Growth (yoy) | -100.00000000000000000000000000000000% |
| Gross Profit (ttm) | N/A |
| EBITDA | -128294000 TWD |
| Net Income Avi to Common (ttm) | -140180000 TWD |
| Diluted EPS (ttm) | -2 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.39B TWD |
| Total Cash Per Share (mrq) | 19.94 TWD |
| Total Debt (mrq) | 7.55M TWD |
| Total Debt/Equity (mrq) | 0.52 TWD |
| Current Ratio (mrq) | 60.563 |
| Book Value Per Share (mrq) | 20.904 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -93761000 TWD |
| Levered Free Cash Flow (ttm) | -51499376 TWD |
Profile of Sinew Pharma Inc.
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | C516, Building C |
| ZIP | 11571 |
| Phone | 886 2 2788 5365 |
| Website | https://www.sinewpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 49 |
Sinew Pharma Inc., a biopharmaceutical company, focuses on the development and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases. The company's products include SNP-610 drug, which is in Phase II clinical trial for treating patients with non-alcoholic steatohepatitis in Taiwan; and SNP-630, a pre-clinical drug for treating patients with non-alcoholic steatohepatitis. It is also developing SNP-810 for use in analgesic and antipyretic indications; and SNP-830 and SNP-840, which are used as hepatotoxicity-free analgesic medicines in the United States. The company was founded in 2014 and is based in Taipei City, Taiwan.
Q&A For Sinew Pharma Inc. Stock
What is a current 6634.TWO stock price?
Sinew Pharma Inc. 6634.TWO stock price today per share is 63.1 TWD.
How to purchase Sinew Pharma Inc. stock?
You can buy 6634.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sinew Pharma Inc.?
The stock symbol or ticker of Sinew Pharma Inc. is 6634.TWO.
Which industry does the Sinew Pharma Inc. company belong to?
The Sinew Pharma Inc. industry is Biotechnology.
How many shares does Sinew Pharma Inc. have in circulation?
The max supply of Sinew Pharma Inc. shares is 71.17M.
What is Sinew Pharma Inc. Price to Earnings Ratio (PE Ratio)?
Sinew Pharma Inc. PE Ratio is now.
What was Sinew Pharma Inc. earnings per share over the trailing 12 months (TTM)?
Sinew Pharma Inc. EPS is -2.07 TWD over the trailing 12 months.
Which sector does the Sinew Pharma Inc. company belong to?
The Sinew Pharma Inc. sector is Healthcare.